94301 ⎘
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring; Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN
#217-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof
#3NOVEL INTERMEDIATE, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF
#4ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE
#5MUSCLE RELAXANT
#6ISOINDOLINES AS PMS2 INHIBITORS
#7SMALL MOLECULE MODULATORS OF FERROPTOSIS
#8Isoquinoline compounds and their use in treating AhR imbalance
#9COMPOSITIONS AND METHODS FOR TREATMENT
#10PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN
#1117-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF
#12Isoquinoline compounds and their use in treating AhR imbalance
#13COMPOUND FOR TREATING ALZHEIMERS DISEASE
#14ANTI-ALS COMPOUNDS
#15Beta-Arrestin-Modulating Compounds and Methods of Using Same
#16Isoquinoline compounds and their use in treating AhR imbalance
#17Isoquinoline compounds and their use in treating AhR imbalance
#18NRF2 ACTIVATOR
#19Fused polycyclic dimers
#20(+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
#21NRF2 activator
#22HDAC8 inhibitors for treating cancer
#23HDAC8 inhibitors for treating cancer
#24(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
#25Substituted berbines and processes for their synthesis
#26C-HALOGEN BOND FORMATION
#27HDAC8 INHIBITORS FOR TREATING CANCER
#28Allosteric inhibitors of thymidylate synthase
#29(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
#30Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#31Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof
#32Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
#33Compositions and methods for treatment
#34Compositions and methods for treatment
#35Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#36Compositions and methods for treatment
#37Compositions and methods for treatment
#38Palladium catalyst, method for its preparation and its use
#39Nitrogen-containing condensed heterocyclic compound
#40Palladium catalyst, method for its preparation and its use
#41One-pot preparation of hexahydroisoquinolines from amides
#42SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS
#43Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#44Compositions and methods for treatment of eye disorders
#45Reversible nondepolarizing neuromuscular blockade agents and methods for their use
#461,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES EFFECTIVE AS ANTIGLIOMA AGENTS, METHODS OF MAKING, AND THEIR USE
#47Isoquinoline derivative
#48Compositions and methods for treatment
#49Compositions and methods for treatment
#50(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
#51One-pot preparation of hexahydroisoquinolines from dihydroisoquinolines
#52One-pot preparation of hexahydroisoquinolines from amides
#53(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
#54Process for the resolution of isoquinoline derivatives
#55R,R-atracurium salts
#56(1R,1′R)-atracurium salts separation process
#57COMPOUNDS AND METHODS FOR MODULATING RHO GTPASES
#58(1R, 1′R)-atracurium salts separation process
#59Compositions and methods for treatment of eye disorders
#60COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#61(1R,1'R)-ATRACURIUM SALTS SEPARATION PROCESS
#62Potassium channel blockers
#63Substituted berbines and processes for their synthesis
#64Preparation of substituted morphinan-6-ones and salts and intermediates thereof
#65Preparation of tetrahydroisoquinolines from dihydroisoquinolines
#66Fungal cell wall synthesis gene
#67Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#68Process for the preparation of hexahydroisoquinolines from 1,2,3,4-tetrahydroisoquinolines
#69Fungal cell wall synthesis gene
#70Isoquinolines as IGF-1R inhibitors
#71FUNGAL CELL WALL SYNTHESIS GENE
#72Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#73Processes for preparing morphinans and intermediates thereof
#74Fungal cell wall synthesis gene
#75Fungal cell wall synthesis gene
#76Opiate intermediates and methods of synthesis
#77Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy
#78Process for the preparation of mivacurium chloride
#79Opiate intermediates and methods of synthesis
#80Extraction of alkaloids from opium
#81Dual function drugs and uses thereof
#82Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food
#83Compositions and methods for treatment of eye disorders
#84Fungal cell wall synthesis gene
#85Fungal cell wall synthesis gene
#86Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
#87Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#88Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions
#89Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#90Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
#91Production of reticuline
#92Process for asymmetric hydrogenation of hexahydroquinoline salts
#93β-Adrenoreceptor agonists, agonist compositions and methods of using
#94Heterocyclic amide compounds as apolipoprotein b inhibitors
#95Compounds and methods for modulation of estrogen receptors